<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">13450</article-id><article-id pub-id-type="doi">10.7554/eLife.13450</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>Nucleosome breathing and remodeling constrain CRISPR‐Cas9 function</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-48031"><name><surname>Isaac</surname><given-names>R Stefan</given-names></name><aff><institution content-type="dept">Department of Biochemistry and Biophysics and Tetrad Graduate Program</institution>, <institution>University of California, San Francisco</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-48032"><name><surname>Jiang</surname><given-names>Fuguo</given-names></name><aff><institution content-type="dept">Department of Molecular and Cell Biology, California Institute for Quantitative Biosciences</institution>, <institution>University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-3402"><name><surname>Doudna</surname><given-names>Jennifer A</given-names></name><aff><institution content-type="dept">Department of Molecular and Cell Biology</institution>, <institution>Howard Hughes Medical Institute, University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-44424"><name><surname>Lim</surname><given-names>Wendell A</given-names></name><aff><institution content-type="dept">Department of Cellular and Molecular Pharmacology</institution>, <institution>Howard Hughes Medical Institute</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" corresp="yes" id="author-19309"><name><surname>Narlikar</surname><given-names>Geeta J</given-names></name><aff><institution content-type="dept">Department of Biochemistry and Biophysics</institution>, <institution>University of California, San Francisco</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country><email>Geeta.Narlikar@ucsf.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-46423"><name><surname>Almeida</surname><given-names>Ricardo AB</given-names></name><aff><institution content-type="dept">Department of Cellular and Molecular Pharmacology, Center for Systems and Synthetic Biology</institution>, <institution>University of California, San Francisco</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-5892"><name><surname>Adelman</surname><given-names>Karen</given-names></name><role>Reviewing editor</role><aff><institution>National Institute of Environmental Health Sciences</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>28</day><month>04</month><year>2016</year></pub-date><elocation-id>e13450</elocation-id><supplementary-material><ext-link xlink:href="elife-13450-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>02</day><month>12</month><year>2015</year></date><date date-type="accepted"><day>16</day><month>04</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Isaac et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Isaac et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>The CRISPR-Cas9 bacterial surveillance system has become a versatile tool for genome editing and gene regulation in eukaryotic cells, yet how CRISPR-Cas9 contends with the barriers presented by eukaryotic chromatin is poorly understood. Here we investigate how the smallest unit of chromatin, a nucleosome, constrains the activity of the CRISPR-Cas9 system. We find that nucleosomes assembled on native DNA sequences are permissive to Cas9 action. However, the accessibility of nucleosomal DNA to Cas9 is variable over several orders of magnitude depending on dynamic properties of the DNA sequence and the distance of the PAM site from the nucleosome dyad.  We further find that chromatin remodeling enzymes stimulate Cas9 activity on nucleosomal templates. Our findings imply that the spontaneous breathing of nucleosomal DNA together with the action of chromatin remodelers allows Cas9 to effectively act on chromatin in vivo.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>None</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Jennifer A Doudna, Co&amp;#x2010;founder of Caribou Biosciences; Editas Medicine; Intellia Therapeutics.</p></fn><fn fn-type="conflict" id="conf3"><p>Wendell A Lim, Founder of Cell Design Labs, and member of its scientific advisory board.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></back></article>